Latest Non-steroidal anti-inflammatory drugs Stories
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer.
A new study reports that any dosage of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) in early pregnancy may cause a woman to miscarry.
The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy.
Patients often take drugs to lower stomach acid and reduce the chances they will develop ulcers from taking their anti-inflammatory drugs for conditions such as arthritis, but the combination may be causing major problems for their small intestines.
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
Boxed warning says daily aspirin doses above 100 milligrams decrease effectiveness SILVER SPRING, Md., July 20, 2011 /PRNewswire-USNewswire/ -- The U.S.
A new study has found that if heart disease patients stop taking aspirin it could raise their heart attack risk.
A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of adverse events during long-term follow-up.
MISSISSAUGA, ON, June 30, 2011 /PRNewswire/ - Nuvo Research Inc.
More Images (1 images) »